IP Library Granted Patent US 10,724,024
Granted Patent B2
US 10,724,024 · App. 16/125,688 · Granted Jul 28, 2020

Cell culture methods for expressing ADAMTS protein

Inventors: Leopold Grillberger (Vienna, AT); Alexandra Spenger (Vienna, AT); Meinhard Hasslacher (Vienna, AT); Rana Grillberger (Vienna, AT); Manfred Reiter (Vienna, AT)
Assignees: Baxalta Incorporated; Baxalta GmbH
C12N9/6489C12N5/0682C12N5/0686C12Y304/24087C12N2500/14C12N2500/22C12N2500/38C12N2500/95C12N2500/99C12N2510/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,024
App. No.
16/125,688
Granted
Jul 28, 2020
Kind
B2
Abstract

The present invention provides culture mediums that are useful for the expression of ADAMTS proteins, such as ADAMTS13. Methods for the expression and purification of ADAMTS proteins are also provided. In some embodiments, the mediums and methods of the invention are useful for the expression of ADAMTS proteins having high specific activities. Also provided are ADAMTS, e.g., ADAMTS13, protein compositions with high specific activities, which are expressed and purified according to the methods provided herein.

Claims (20)

1. A method for expressing a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) protein, the method comprising culturing, by continuous cultivation, a mammalian cell harboring a nucleic acid encoding an ADAMTS protein in a culture medium comprising at least 3 μM zinc, wherein the continuous cultivation includes maintaining a cell density of from 1×10 6 cells/mL to 4×10 6 cells/mL for at least seven days.

2. The method of claim 1 , wherein the culture medium comprises from 3 μM to 12 μM zinc.

3. The method of claim 1 , wherein the culture medium comprises about 5 μM zinc.

4. The method of claim 1 , wherein the culture medium further comprises from 0.5 mM to 1.5 mM calcium.

5. The method of claim 2 , wherein the culture medium further comprises from 0.5 mM to 1.5 mM calcium.

6. The method of claim 3 , wherein the culture medium further comprises from 0.5 mM to 1.5 mM calcium.

7. The method of claim 1 , wherein the mammalian cell is selected from the group consisting of a CHO cell, a BHK cell, and an HEK cell.

8. The method of claim 2 , wherein the mammalian cell is selected from the group consisting of a CHO cell, a BHK cell, and an HEK cell.

9. The method of claim 3 , wherein the mammalian cell is selected from the group consisting of a CHO cell, a BHK cell, and an HEK cell.

10. The method of claim 1 , wherein the continuous cultivation is chemostatic cell cultivation.

11. The method of claim 2 , wherein the continuous cultivation is chemostatic cell cultivation.

12. The method of claim 3 , wherein the continuous cultivation is chemostatic cell cultivation.

13. The method of claim 8 , wherein the continuous cultivation is chemostatic cell cultivation.

14. The method of claim 1 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

15. The method of claim 2 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

16. The method of claim 3 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

17. The method of claim 8 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

18. The method of claim 10 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

19. The method of claim 11 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

20. The method of claim 13 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055188/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2019
From: GRILLBERGER, LEOPOLD; SPENGER, ALEXANDRA; HASSLACHER, MEINHARD; GRILLBERGER, RANA; REITER, MANFRED
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 050226/0274 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2019
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 050240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2019
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 050240/0297 →